IMPORTANCE Breast cancer surgery, the most common cancer operation performed in nursing home residents, is viewed as a low-risk surgical intervention. However, outcomes in patients with high functional dependence and limited life expectancy are poorly understood.
B reast cancer surgery is the most common cancer operation performed in nursing home residents, comprising 61% of such procedures. 1 More than half of nursing home physicians report encountering residents with suspected breast cancer through screening or physical examination. A total of 67% of these patients are referred for diagnosis and treatment. 2 Because most breast cancer clinical trials have excluded women who are older, frail, and cognitively impaired, treatment outcomes in this population are uncertain.
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Clinical practice guidelines in oncology demonstrate consensus that breast cancer treatment decisions for older women, including surgery, should be individualized based on treatment benefits and harms as well as patient preferences. 4 The benefits of breast cancer surgery may not be realized in patients who have competing risks from significant comorbid disease. For those with limited life expectancy, long-term mortality benefits from surgical treatment of breast cancer are unlikely to be gained. Although operative mortality after breast cancer surgery is low in the general population, the burdens of surgery (eg, functional disability) can be substantial. Regardless of procedure type (eg, lumpectomy, axillary lymph node dissection [ALND] ), more than one-third of middle-aged women report poor range of motion or pain that affects their upper body function 6 months after breast surgery, even after lumpectomy alone. [5] [6] [7] Poor range of motion in the arm can result in diminished ability to perform important activities of daily living (ADLs), such as feeding and toileting independently, in older populations. In nursing home residents with limited life expectancy, because death from other causes may occur before breast cancer causes symptoms and pain, a better understanding of surgical morbidity is important for decision making in this population. In addition, understanding the functional trajectory after breast cancer surgery in nursing home residents is essential for making realistic informed decisions. Using Medicare and national nursing home data, we evaluated mortality and functional decline in female residents who underwent inpatient breast cancer surgery in the United States and identified patient characteristics associated with mortality and functional disability after surgery.
Methods

Patients and Databases
We identified a cohort of female long-term nursing home residents (age ≥67 years) who underwent an inpatient breast cancer surgical procedure by linking data from 100% national Medicare inpatient files (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) with the Minimum Data Set (MDS) for nursing homes (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) . The Medicare inpatient files contain discharge information for all fee-forservice inpatient hospitalizations for Medicare beneficiaries. The MDS is a mandatory assessment of all nursing home residents who reside in facilities participating in Medicare or Medicaid programs. The MDS assessments of a resident's health and functional status are administered by nursing staff and are completed quarterly at the time of admission or readmission to the nursing facility and when the resident experiences a change in clinical status. This study was approved by the University of California, San Francisco Committee on Human Research, which determined that informed consent was not required. The cohort was identified using International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes for breast cancer and procedure codes for lumpectomy, mastectomy, and ALND with a lumpectomy or mastectomy in the Medicare inpatient file (eAppendix in the Supplement). For the small number of residents who underwent multiple breast procedures, we used the first index case. Patients were classified as long-term nursing home residents if they underwent 2 or more consecutive MDS assessments more than 90 days apart during the 6 months before surgery confirming a preoperative nursing home length of stay for more than 90 days.
Data Collection and Measurement
Outcome Variables
We assessed 30-day mortality, 1-year mortality, and 1-year functional decline after surgery. Death was assessed using the Medicare Denominator File. Functional status was measured by trained evaluators using MDS assessments of a resident's selfperformance of the ADLs. Data on performance of ADLs in the MDS include questions about physical function in 7 activities: dressing, eating, toileting, personal hygiene, bed mobility, transferring, and ambulation. Performance of each of these activities is rated using a scoring system from 0 (independence) to 4 (total dependence). The Minimum Data Set Activities of Daily Living (MDS-ADL) score is a sum of these 7 scores and has been validated against standardized measures of function and ranges from 0, indicating independence in all activities, to 28, indicating total dependence in all activities.
8 Consistent with previously published studies, 9,10 we defined functional decline as an increase of 2 or more points in the MDS-ADL score.
Resident Characteristics
Demographic data were obtained from the Medicare Denominator File and comorbid diagnoses from MDS assessments.
Residents were categorized as having cognitive impairment if they had 1 of the following: (1) a dementia diagnosis in the
Key Points
Question What are long-term functional and mortality outcomes among older female residents of nursing homes after breast cancer surgery?
Findings In this study of 5969 female nursing home residents, the highest 30-day and 1-year mortality occurred after lumpectomy (least invasive procedure) and the greatest 1-year functional decline occurred after lumpectomy or mastectomy with axillary lymph node dissection (most invasive procedure). Among all patients who underwent breast cancer surgery, poor preoperative function was associated with 1-year mortality, and preoperative functional decline and cognitive impairment were associated with 1-year postoperative functional decline.
Meaning Surgical decision making for female nursing home residents with breast cancer may need to consider preoperative function and cognitive impairment. We defined baseline functional status as the MDS-ADL summary score reported on the most recent MDS assessment before the breast cancer surgery. In addition, we categorized residents as experiencing preoperative functional decline by comparing the 2 most recent MDS reports collected before surgery and determining whether there was an increase of 2 or more points in the MDS-ADL score. To explore the association between preoperative functional status and postoperative mortality and functional decline, we divided nursing home residents into 4 approximately equal-sized quartiles of functional status based on their preoperative MDS-ADL summary score.
Statistical Analysis
For our primary analyses, we examined the association of patient characteristics with outcomes stratified by procedure type. We used the Kaplan-Meier method to estimate cumulative incidence of 1-month and 1-year mortality from the date of surgery. Then, we used Cox proportional hazards regression models to estimate the adjusted and unadjusted hazard ratios (HRs) for 1-year mortality associated with individual resident characteristics. We fit Fine-Gray competing risk models 13 to estimate the subhazard ratios (sHRs) for functional decline during the 12-month follow-up associated with individual resident characteristics, taking into account the competing risk of mortality.
In all analyses, the patient was the unit of analysis. Statistical significance was defined as P < .05 using 2-sided tests with a 5% α level. Analysis was performed using SAS statistical software, version 9.4 (SAS Institute Inc). The figures were drawn using R version 3.1.1 (R Foundation for Statistical Computing). 
Results
Baseline Characteristics
30-Day and 1-Year Mortality Outcomes
The observed 30-day mortality rate was 3.2%, with the highest rate among those who underwent lumpectomy alone (8.5%). In multivariate analysis, for all subcohorts, surgery performed during an urgent or emergency admission was associated with a higher risk of 30-day mortality (lumpectomy: adjusted HR, 4.07 [95% CI, 1.85-8.95], P < .001; mastectomy: adjusted HR, 1.91 [95% CI, 1.09-3.32], P = .02; ALND: adjusted HR, 1.82; 95% CI [1.11-2.99], P = .02) (eTable 1 in the Supplement). For all subcohorts, age, comorbidities, functional decline before surgery, and hospital admission within 1 year before surgery were not significantly associated with 30-day mortality. In the ALND subcohort, severe functional disability at baseline was associated with the highest 30-day mortality risk (adjusted HR, 2.90; 95% CI, 1.32-6.37; P = .008).
One-year all-cause mortality was 31% to 42%. The residents in the most functionally dependent quartiles experienced high mortality in all 3 subcohorts (Figure) . In a multivariate analysis, an MDS-ADL score of 20 to 28 (indicating significant ADL dependence) was associated with death at 1 year compared with an MDS-ADL score of 0 to 7 (lumpectomy: HR, 
Functional Decline
Among patients who survived 1 year, 55% to 60% had a functional decline. These patients experienced clinically significant functional decline at 1 year after surgery: mean MDS-ADL score decreased by 2.8 points after lumpectomy, 4.1 points after mastectomy, and 4.6 points after ALND. In multivariate analysis, for all subcohorts, ADL decline before surgery was associated with an increased risk of 1- 
Discussion
In a national registry of all elderly women residing in nursing homes in the United States who underwent an inpatient breast cancer operation from 2003 to 2013, more than half were cognitively and functionally impaired before their surgery. Of 5969 breast cancer operations, 3661 (61.3%) were of the most invasive type (ie, a lumpectomy or mastectomy with an ALND). Among 666 patients who underwent the least invasive type of breast surgery (ie, lumpectomy alone), 56 (8.4%) died within 30 days of surgery. Overall, 1842 of 5969 (30.9%) died within a year of their breast cancer surgery, and among those women who survived 1 year, 3478 of 5969 (58.3%) experienced significant functional decline. Poor function before surgery was significantly associated with an increased risk of 1-year mortality across all breast cancer surgery types. In addition, those with the least functional dependency before surgery were most likely to have a 1-year functional decline in any of the breast cancer surgery operations. Cognitive impairment and ADL decline before surgery were independent risk factors associated with 1-year functional decline among patients undergoing any of the breast cancer surgery operations.
Our findings differ from a prior analysis 14 that examined mortality after breast cancer surgery. This prior analysis 14 of 30-day mortality in community-dwelling women after breast cancer surgery reported a mortality rate of 1%. In the nursing home cohort in our study, 30-day mortality ranged from 2% to 8%, depending on surgery type. The highest mortality rate was associated with the least invasive procedure (ie, lumpectomy, 8.4%), which appeared to be performed in the sickest patients. A higher mortality rate is somewhat expected because of advanced age and increased comorbidities in nursing home residents. However, a 30-day mortality of 8.4% is higher than would be anticipated for a surgical procedure that is generally considered to be low risk. It is likely that the patients identified as high risk were offered lumpectomy only in an attempt to minimize morbidity. In ad- dition, because lumpectomies are typically outpatient procedures, this cohort of women represent patients in whom inpatient stay was deemed to be necessary after lumpectomy alone, likely implying a greater baseline risk than can be captured in administrative databases. Although this is the first study, to our knowledge, to examine long-term functional loss in older nursing home residents undergoing breast cancer surgery, long-lasting functional loss has been reported in younger cohorts. Regardless of procedure type (eg, lumpectomy, ALND), more than onethird of middle-aged women report poor range of arm movement affecting their upper body function 6 months after breast surgery, with some reporting this problem up to 18 months after breast surgery. 5 In the nursing home cohort in our study, 1-year functional decline occurred in 3478 of 5969 patients (58.3%) still alive at 1 year. A higher rate of worsening function after breast cancer surgery is expected in a nursing home population. Because of the high rates of cognitive impairment in this population and the association of cognitive impairment with poor functional recovery after surgical insults among older adults, the likelihood of breast cancer surgery and affecting a frail, elderly woman's function in the long term is plausible and likely.
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A high proportion of our cohort underwent ALND, which is consistent with a cohort who underwent inpatient surgery. However, because ALND has no proven survival benefit in breast cancer, the potential benefit of ALND would be for staging to determine need for adjuvant therapy, such as chemotherapy, or for locoregional control. 16 Given the hesitancy to administer chemotherapy to elderly nursing home residents that was reflected in low chemotherapy use in this population, the staging benefits of ALND were significantly diminished. 1 Although omitting surgery for locoregional disease management may be considered to be suboptimal in the treatment of breast cancer, our findings of significant risk of morbidity and mortality after surgical intervention in this patient population may provide evidence that nonsurgical treatment may be preferable. 17 Our data do not permit analyzing outcomes by tumor subtype or stage, but multimodal therapy for breast cancer could potentially offer alternative nonsurgical treatment options. Estrogen receptor-positive tumors may be at least temporarily treated with endocrine therapy; for those with bulky adenopathy, radiotherapy without surgery could also be considered. 18, 19 In addition to the pain reported in prior studies 5-7 in younger women undergoing any breast surgery, the consequences of breast cancer surgery in an even older and frailer population are likely to be even greater. For example, a qualitative study by Walter et al 20 describes an 89-year-old woman with angina and dementia who was functionally dependent in 2 ADLs and diagnosed with invasive ductal carcinoma. She subsequently received a modified radical mastectomy, with no evidence of cancer in her axillary lymph nodes. The night after surgery, she pulled off all the bandages, requiring restraints, and developed a seroma. She died 15 months later of a myocardial infarction. The present study provides new benchmark data for women who are long-term nursing home residents and provides essential information for individualizing surgical decision making when breast cancer surgery is being considered. There is a paucity of data about the long-term functional and 248  260  273  284  300  310  332  276  289  300  316  337  356  383  324  348  365  382  412  451  482  256  284  318  343  369  403 667  711  742  776  810  844  872  591  639  677  716  752  796  835  717  759  808  869  941  1012  1076  535  585  632  683  737  812  878 The Minimum Data Set for Nursing Home Activities of Daily Living (MDS-ADL) includes information about mobility in 7 activities: mobility while in bed, transferring, ambulation, dressing, eating, toileting, and personal hygiene. Performance of each of these ADLs is rated using a scoring system of 0 to 4 points, ranging from 0, indicating independence, to 4, indicating total dependence. Possible total scores range from 0, for independence in all ADLs, to 28, indicating total dependence in all ADLs.
Research Original Investigation
Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents mortality outcomes of breast cancer surgery in the nursing home population. Realistic, evidence-based information about fatal and functional outcomes is needed to make informed consent and anticipatory guidance meaningful for those who decide to undergo breast cancer surgery. Although some practitioners, patients, and caregivers believe breast surgery is necessary to prevent morbidity and mortality from breast cancer, the risks of harm may outweigh the benefit in this frail, vulnerable population, in which many have a limited life expectancy. Our study found high mortality rates among nursing home residents who undergo breast cancer surgery. Overall, the nursing home resident mortality rate has been reported to be 25%, and in this surgical cohort, it was 30.9%. 21, 22 In addition, among those undergoing a more invasive and functionally impairing procedure (ie, ALND), their ability to care for themselves worsened. Breast cancer care should be individualized, goal-oriented care, and hormonal therapy or symptom management should only be considered options for nursing home residents.
Further evaluation of breast cancer surgery in the longterm nursing home population should be performed. First, a study that evaluates specifically nursing home residents undergoing breast cancer surgery in the outpatient setting should be designed. This group will provide information on outcomes after surgery in a likely less frail and sick nursing home population. Second, to better inform patients of outcomes specifically related to the surgery, a study that compares outcomes of nursing home residents with and without the surgical intervention should be developed and studied. Third, decision aids to support informed decision making in a frail nursing home population that is considering breast cancer surgery should be developed and studied. This future direction may further inform surgical decision making in nursing home residents possibly considering breast cancer surgery.
Limitations
There are potential limitations to consider. First, we did not have information on outpatient services, thereby missing procedures performed in the outpatient setting. However, our goal was to evaluate the sickest patients who would most likely have their procedure performed in the inpatient setting. Second, because the MedPAR file and the MDS do not have information about outpatient services, we did not have information about endocrine therapy, chemotherapy, and radiation therapy that may have been used in conjunction with or instead of inpatient surgery and may have influenced function and mortality. In addition, we did not have information on staging of the breast cancer. Prior research, however, has found that only 6% of nursing home residents with cancer receive radiation therapy or chemotherapy.
1 Third, the MedPAR file and the MDS do not contain data about the anesthesia type; therefore, we were unable to assess the association between the type of anesthesia and outcomes. Fourth, we recognize that the patient's death or worsening function may or may not be directly attributable to surgery. Fifth, our data set cannot identify nursing home residents with newly diagnosed breast cancer who did not undergo surgery or those who underwent outpatient surgery. However, sicker nursing home residents may not be deemed candidates for surgery. Therefore, these data may not be generalizable to the sickest of all nursing home residents and may underestimate the harms of surgery.
Conclusions
Our findings suggest that elderly female nursing home residents who undergo breast cancer surgery are at high risk of 1-year mortality and functional decline. These findings establish benchmark data for this population and provide cautionary information for practitioners considering offering breast cancer surgery with the hope of prolonging life or improving functioning in frail older women with cognitive and significant functional impairment. Surgery often is associated with curing cancer but can worsen other, more life-limiting comorbidities and function of nursing home residents. This information is essential to guide surgical decision making in frail older women with breast cancer and suggests that multimodality therapy be considered as an alternative to surgery in this population. . This cohort of patients had high levels of preoperative comorbidities and functional dependence. The authors found significantly higher rates of 30-day mortality, 1-year mortality, and functional decline in this cohort, and those who were the least functionally independent had the highest mortality rates. This evaluation of surgery in nursing home patients highlights some important issues to consider about caring for the very elderly. Screening guidelines generally recommend ceasing screening at age 75 years; however, a 2014 study recommended continued screening past age 75 years if the individuals are in good health and life expectancy is expected to be longer than 10 years. 3 Given that nursing home patients are unlikely to meet these criteria, there is the question of whether they should undergo any screening for breast cancer. The more complicated issue arises with a palpable breast mass or nodal disease. In these instances, patient life expectancy, functional status, surgical risk, and the natural history of breast cancer must be considered, and there are formal tools to offer estimates for these domains. First, life expectancy can be estimated from calculators such as the ones found on the ePrognosis website (https://eprognosis.ucsf.edu/ The ADL performance in the Minimum Data Set for Nursing Home (MDS) includes information about mobility in 7 activities: mobility while in bed, transferring, ambulation, dressing, eating, toileting, and personal hygiene. Performance of each of these ADLs is rated using a scoring system of 0 to 4 points, ranging from 0, indicating independence, to 4, indicating total dependence. Possible total scores range from 0, for independence in all ADLs, to 28, indicating total dependence in all ADLs. Residents were classified as having Functional decline before surgery if they had a 2-point or greater MDS-ADL score increase in the 3 months before their surgical admission. The ADL performance in the Minimum Data Set for Nursing Home (MDS) includes information about mobility in 7 activities: mobility while in bed, transferring, ambulation, dressing, eating, toileting, and personal hygiene. Performance of each of these ADLs is rated using a scoring system of 0 to 4 points, ranging from 0, indicating independence, to 4, indicating total dependence. Possible total scores range from 0, for independence in all ADLs, to 28, indicating total dependence in all ADLs. Residents were classified as having Functional decline before surgery if they had a 2-point or greater MDS-ADL score increase in the 3 months before their surgical admission. The ADL performance in the Minimum Data Set for Nursing Home (MDS) includes information about mobility in 7 activities: mobility while in bed, transferring, ambulation, dressing, eating, toileting, and personal hygiene. Performance of each of these ADLs is rated using a scoring system of 0 to 4 points, ranging from 0, indicating independence, to 4, indicating total dependence. Possible total scores range from 0, for independence in all ADLs, to 28, indicating total dependence in all ADLs.
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